. Author manuscript; available in PMC: 2018 Oct 26.

Published in final edited form as: J Autoimmun. 2016 May 6;75:30–38. doi: 10.1016/j.jaut.2016.04.008

Table 2.

Pregnancy outcomes in mice treated with NHIgG, APS-mice, APS-mice treated with HCQ and mice treated with HCQ alone. Fetal resorption frequency (FRF) was calculated as the number of resorptions divided by the total number of resorptions plus viable fetuses. N=6-7 / experimental group. * different from NHIgG, p<0.05

	FRF(%)	Placenta (mg)	Fetus (mg)
NHIgG	10.4±5.9	122±9.9	401.5±22.8
APS	54.2±11.1*	87.5±9.6*	302.1±18.5*
APS +HCQ	11.0±5.7	115.8±11.3	385.1±21.5
HCQ	10.9±1.0	131±15.3	398.3±19.5